Brian Neel - 29 Apr 2022 Form 4/A - Amendment Insider Report for MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)

Role
Chief Operating Officer, Nucleic Acid Production
Signature
/s/ Kurt Oreshack, by power of attorney for Brian Neel
Issuer symbol
MRVI
Transactions as of
29 Apr 2022
Net transactions value
+$13,127
Form type
4/A - Amendment
Filing time
27 Jun 2022, 19:55:38 UTC
Date Of Original Report
27 Jun 2022
Previous filing
27 Jan 2022
Next filing
09 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRVI Class A Common Stock Award $13,127 +572 +3.2% $22.95 18,456 29 Apr 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Amended to note that this is a voluntary filing. The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 572 shares of Class A Common Stock was exempt pursuant to Rule 16b-3.

Remarks:

Chief Operating Officer, Nucleic Acid Production